14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 18 days ( 56.00 % )
Last Price $0.0011 0 %
High/ Low $0.0011 - $0.0011 0%
Chg 7 Days N/A $0.0011 $0.0011
Chg 30 Days 83.33 % $0.0006 $0.0011
Chg 12 mos -97.80 % $0.0500 $0.0011
Trend - 3 mos -68.88 % Width: 269.23 %
Trend - 12 mos -69.98 % Width: 281.13 %
Pred. range - 3 mos N/A - $0.0006 -100.00 % - -49.44 %
Pred. range - 12 mos N/A - $0.0083 -100.00 % - 658.43 %
Short MA avg 3 mos Sell Apr 17, 2024 - 12 days
Long MA avg 3 mos Sell Apr 17, 2024 - 12 days
Short/Long MA avg 3 mos Sell Apr 23, 2024 - 8 days
Short MA avg 12 mos Sell Apr 17, 2024 - 12 days
Long MA avg 12 mos Buy Jan 08, 2024 - 81 days
Short/Long MA avg 12 mos Sell Jan 04, 2024 - 83 days
Pivot Short Sell Apr 17, 2024 - 12 days
Bollinger Buy Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Scopus BioPharma Inc.

Scopus BioPharma. Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule... SCPS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT